Cost-effective jaundice testing developed for low-resource hospitals
The Rice360 Institute for Global Health Technologies has validated the accuracy of its latest testing technology for newborn jaundice. BiliDx addresses a critical gap in the availability of accurate, affordable, point-of-care jaundice testing in low-resource hospitals.
Tiny, flexible spinal probe system could lead to better therapies
A $6.25 million National Institutes of Health grant supports Rice U. engineers optimizing a neural probe array that can record the activity of spinal cord neurons as bodies move and behave. Scientists would also develop an integrated data-processing and stimulation-feedback system.
Rice lab’s boron nitride composite could be useful for advanced technology applications
Rice University scientists have found that a boron nitride nanocomposite interacts with light and heat in unexpected ways that could be useful for advanced technology applications.
Las Vegas; Miami; Louisville, Kentucky; Orlando, Florida; and Grand Rapids, Michigan top the list of cities at greatest risk of losing jobs to artificial intelligence (AI), according to a report from the Chamber of Commerce, a business research company.
Rice University experts are available to comment on a new report from the Chamber of Commerce predicting that Houston stands to lose as many as 12% of jobs due to AI by 2027.
Rice U. program in Costa Rica promotes medical innovation
Rice University’s Global Medical Innovation program combines engineering, business and clinical training to help students solve real-world medical needs.
New software designs optimized, personalized treatments for movement impairments
A team of Rice University engineers has launched open-source software that constructs and uses personalized computer models of how individual patients move to optimize treatments for neurologic and orthopedic mobility impairments.
Rice U.’s Kaiyu Hang wins NSF CAREER Award
Kaiyu Hang, an assistant professor of computer science at Rice University, has won a National Science Foundation CAREER Award to develop robots that can manipulate unfamiliar objects in high-uncertainty situations.
Rice U. experts available to comment on White House AI briefing
Rice University AI experts Fred Oswald and Moshe Vardi are registered to attend a White House briefing this afternoon and are available to comment on its proceedings and likely challenges and potential outcomes of recent developments in AI industry advancements and regulation.
Rice researchers earn prestigious Defense Department grants
Rice professors Qimiao Si and Jeffrey Tabor are recipients of prestigious 2023 Vannevar Bush Faculty Fellowships from the Department of Defense.
Discovery may lead to terahertz technology for quantum sensing
Rice University researchers leverage the quantum properties of strontium titanate to make a broad terahertz frequency range useful for quantum control and sensing applications.
Rice U. expert available to discuss Llama 2 launch
The new open-source large language model, Llama 2, launched by Facebook parent company, Meta, last Tuesday allows users to adapt and develop artificial intelligence tools ⎯ including for use in commercial products ⎯ but the move raises urgent questions about the risks and potential benefits to how information is produced and disseminated.
Device makes hydrogen from sunlight with record efficiency
Rice University engineers’ have created a device that turns sunlight into hydrogen with record-breaking efficiency by integrating next-generation halide perovskite semiconductors with electrocatalysts in a single, durable, cost-effective and scalable device.
Michael Wong named fellow of the Royal Society of Chemistry
Rice University’s Michael Wong was named a fellow to the Royal Society of Chemistry, the oldest chemical society in the world, whose mission is to “advance excellence in the chemical sciences.”
NIH grant backs Rice lab’s sickle cell disease research
Rice University bioengineer Gang Bao and his team have won a grant from the National Institutes of Health to address critical questions surrounding the safety and efficacy of using gene editing to treat sickle cell disease.
